FASTER
FASTER
Getting effective treatments to patients quicker
By unlocking faster cell recovery, delivering higher yields, and simplifying manufacturing processes, cell therapy innovators can achieve radically shortened vein-to-vein times.
SCALABLE
SCALABLE
From millions to billions seamlessly
Cells move through the channels in an identical manner to ensure the highest quality of engineered cells at any scale – from millions to billions. Scale is elegantly achieved by increasing the number of channels from laboratory experiments to clinical, large-volume applications.
ACCESSIBLE
ACCESSIBLE
Lower costs to manufacture
Simplified workflows and unparalleled scalability provide significant time and cost efficiencies in the development and manufacturing of cell therapies, enabling the rapid and seamless transition from laboratory to clinical, large-volume applications.
EFFECTIVE
EFFECTIVE
Higher potency and durability of cell therapies
Reduced expansion time results in higher quality of manufactured cells and a higher percentage of stem memory cells – the best predictors of cell therapy success in the treatment of cancer.
THE INFINITY TECHNOLOGY
A paradigm shift for cell therapy manufacturing
The InfinityTM technology produces the highest quality of edited cells – vital to advanced cell therapies. Cells recover rapidly to enable multiple sequential editing events, resulting in high yields of edited cells with exceptional proliferative capacity.
THE INFINITY ADVANTAGE
Removing limitations to improve therapeutics outcomes
Our microfluidics process ensures rapid genome editing of cells in a manner that retains cell quality – eliminating risk of genotoxicity and chromosomal abnormalities.
Conventional manufacturing processes introduce unintended genetic mutations, posing greater risk to patients.
VIRAL TRANSDUCTION
Random integration and insertional mutagenesis
ELECTROPORATION
Risk of genomic translocations
Changing the game in cell therapy workflows
Currently, best in class cell therapy workflows are achieved by deploying expensive, lengthy, and error-prone processes that span multiple unit operations.
We envision a future where treatments are produced point-of-care. With the Infinity™ microfluidic solution, simplicity of operation allows our partners to seamlessly integrate, scale up, down, and out, to enable expansion into decentralized, closer to the patient, point of care treatments.